LSV Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-69,800
Closed -$2.12M 905
2022
Q2
$2.12M Sell
69,800
-129,541
-65% -$3.5M ﹤0.01% 602
2022
Q1
$5.17M Sell
199,341
-212,937
-52% -$5.07M 0.01% 520
2021
Q4
$8.41M Buy
412,278
+25,850
+7% +$496K 0.01% 475
2021
Q3
$7.43M Sell
386,428
-13,400
-3% -$267K 0.01% 487
2021
Q2
$8.87M Sell
399,828
-5,400
-1% -$115K 0.02% 477
2021
Q1
$10.6M Buy
405,228
+111,928
+38% +$2.66M 0.02% 458
2020
Q4
$5.48M Buy
293,300
+276,500
+1,646% +$5.16M 0.01% 544
2020
Q3
$285K Buy
+16,800
New +$327K ﹤0.01% 841
2020
Q1
Sell
-109,800
Closed -$1.07M 973
2019
Q4
$1.07M Hold
109,800
﹤0.01% 752
2019
Q3
$1.04M Buy
109,800
+11,500
+12% +$121K ﹤0.01% 742
2019
Q2
$1.17M Hold
98,300
﹤0.01% 740
2019
Q1
$1.73M Sell
98,300
-28,400
-22% -$472K ﹤0.01% 694
2018
Q4
$2.2M Sell
126,700
-23,500
-16% -$401K ﹤0.01% 670
2018
Q3
$2.24M Sell
150,200
-13,900
-8% -$216K ﹤0.01% 709
2018
Q2
$2.61M Hold
164,100
﹤0.01% 703
2018
Q1
$2.33M Buy
+164,100
New +$2.43M ﹤0.01% 698

Other funds holding VIVO

LSV Asset Management's VIVO Position: Q3 2022 in Review

LSV Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 69,800 shares — an estimated $2.12M sold.

LSV Asset Management first reported a position in VIVO in Q1 2018 and held it in 16 quarters. The position peaked at $10.6M in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • LSV Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • LSV Asset Management sold 69,800 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.12M.
  • LSV Asset Management first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 16 quarters.
  • LSV Asset Management's Meridian Bioscience Inc position peaked at $10.6M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on LSV Asset Management's 13F filing for Q3 2022, filed 4 Nov 2022.